Document is current

Addition von Ramucirumab zu FOLFIRI in der Zweitlinie

Crossref DOI link: https://doi.org/10.1007/s15004-015-0982-7

Published Online: 2015-11-13

Published Print: 2015-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy